A
Price
$113.92
Change
-$2.44 (-2.10%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
42.66B
40 days until earnings call
OSUR
Price
$3.21
Change
-$0.07 (-2.13%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
453.85M
25 days until earnings call
Interact to see
Advertisement

A vs OSUR

Header iconA vs OSUR Comparison
Open Charts A vs OSURBanner chart's image
Agilent Technologies
Price$113.92
Change-$2.44 (-2.10%)
Volume$11.97K
Capitalization42.66B
OraSure Technologies
Price$3.21
Change-$0.07 (-2.13%)
Volume$9.39K
Capitalization453.85M
A vs OSUR Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OSUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. OSUR commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and OSUR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 19, 2025
Stock price -- (A: $116.36 vs. OSUR: $3.28)
Brand notoriety: A and OSUR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 74% vs. OSUR: 87%
Market capitalization -- A: $42.66B vs. OSUR: $453.85M
A [@Medical Specialties] is valued at $42.66B. OSUR’s [@Medical Specialties] market capitalization is $453.85M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileOSUR’s FA Score has 1 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • OSUR’s FA Score: 1 green, 4 red.
According to our system of comparison, A is a better buy in the long-term than OSUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while OSUR’s TA Score has 5 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 4 bearish.
  • OSUR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, OSUR is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а -6.29% price change this week, while OSUR (@Medical Specialties) price change was +7.54% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.65%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was -2.13%.

Reported Earning Dates

A is expected to report earnings on Aug 27, 2025.

OSUR is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical Specialties (-0.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than OSUR($454M). A has higher P/E ratio than OSUR: A (34.82) vs OSUR (8.44). OSUR YTD gains are higher at: -9.141 vs. A (-13.017). A has higher annual earnings (EBITDA): 1.69B vs. OSUR (64.4M). OSUR has less debt than A: OSUR (13.5M) vs A (2.56B). A has higher revenues than OSUR: A (6.74B) vs OSUR (405M).
AOSURA / OSUR
Capitalization42.7B454M9,405%
EBITDA1.69B64.4M2,624%
Gain YTD-13.017-9.141142%
P/E Ratio34.828.44412%
Revenue6.74B405M1,663%
Total CashN/A290M-
Total Debt2.56B13.5M18,926%
FUNDAMENTALS RATINGS
A vs OSUR: Fundamental Ratings
A
OSUR
OUTLOOK RATING
1..100
166
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
69
Overvalued
PROFIT vs RISK RATING
1..100
68100
SMR RATING
1..100
4792
PRICE GROWTH RATING
1..100
6258
P/E GROWTH RATING
1..100
626
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for OSUR (69) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than OSUR’s over the last 12 months.

A's Profit vs Risk Rating (68) in the Biotechnology industry is in the same range as OSUR (100) in the Medical Specialties industry. This means that A’s stock grew similarly to OSUR’s over the last 12 months.

A's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for OSUR (92) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than OSUR’s over the last 12 months.

OSUR's Price Growth Rating (58) in the Medical Specialties industry is in the same range as A (62) in the Biotechnology industry. This means that OSUR’s stock grew similarly to A’s over the last 12 months.

OSUR's P/E Growth Rating (6) in the Medical Specialties industry is somewhat better than the same rating for A (62) in the Biotechnology industry. This means that OSUR’s stock grew somewhat faster than A’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AOSUR
RSI
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
63%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 3 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
60%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OSUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ELFNX94.18N/A
N/A
Elfun Trusts
GCSAX25.99N/A
N/A
Goldman Sachs Small Cap Eq Insghts A
SMAPX10.34N/A
N/A
Westwood Salient MLP & Engy Infras A
AVEWX21.92N/A
N/A
Ave Maria World Equity
LSEIX16.03N/A
N/A
Persimmon Long/Short I

OSUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, OSUR has been loosely correlated with IQV. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if OSUR jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSUR
1D Price
Change %
OSUR100%
+5.47%
IQV - OSUR
45%
Loosely correlated
+2.91%
MTD - OSUR
42%
Loosely correlated
+1.81%
RVTY - OSUR
41%
Loosely correlated
+0.72%
INGN - OSUR
40%
Loosely correlated
+2.14%
A - OSUR
39%
Loosely correlated
+2.58%
More